ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.23
0.00%
US Tech 100
19,601.20
0.11%
S&P 500
5,745.37
0.00%
US Dollar vs CAD
1.34838
0.05%
Bitcoin
65,767.98
0.90%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vanda Pharmaceuticals Inc (VNDA)

  7. Vanda Pharmaceuticals Inc (VNDA) News

VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VNDA
DateTimeSourceHeadlineSymbolCompany
09/19/20247:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VNDAVanda Pharmaceuticals Inc
09/19/20246:00AMPR Newswire (US)FDA Declines to Approve Vanda's Marketing Application for Tradipitant in GastroparesisNASDAQ:VNDAVanda Pharmaceuticals Inc
09/11/20244:00PMPR Newswire (US)Vanda Pharmaceuticals Announces Participation in the 2024 Cantor Global Healthcare ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
09/04/20244:13PMPR Newswire (US)Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
08/29/20243:30PMPR Newswire (US)Vanda Pharmaceuticals Announces Participation in the Wells Fargo 2024 Healthcare ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
08/08/20246:47AMEdgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]NASDAQ:VNDAVanda Pharmaceuticals Inc
08/08/20246:29AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VNDAVanda Pharmaceuticals Inc
08/01/20246:01AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VNDAVanda Pharmaceuticals Inc
07/31/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VNDAVanda Pharmaceuticals Inc
07/31/20243:01PMPR Newswire (US)Vanda Pharmaceuticals Reports Second Quarter 2024 Financial ResultsNASDAQ:VNDAVanda Pharmaceuticals Inc
07/29/20244:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VNDAVanda Pharmaceuticals Inc
07/29/20244:21PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VNDAVanda Pharmaceuticals Inc
07/26/20248:19AMPR Newswire (US)Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024NASDAQ:VNDAVanda Pharmaceuticals Inc
07/01/20247:01AMPR Newswire (US)Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and ApotexNASDAQ:VNDAVanda Pharmaceuticals Inc
06/19/20247:48PMPR Newswire (US)Vanda Pharmaceuticals Board of Directors Determines that Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and its ShareholdersNASDAQ:VNDAVanda Pharmaceuticals Inc
06/13/20243:38PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VNDAVanda Pharmaceuticals Inc
06/13/20249:02AMPR Newswire (US)Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future PakNASDAQ:VNDAVanda Pharmaceuticals Inc
06/06/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VNDAVanda Pharmaceuticals Inc
06/06/20248:24AMPR Newswire (US)Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.NASDAQ:VNDAVanda Pharmaceuticals Inc
05/30/20244:20PMPR Newswire (US)Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
05/30/20243:48PMPR Newswire (US)Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®NASDAQ:VNDAVanda Pharmaceuticals Inc
05/29/20241:17PMPR Newswire (US)Vanda Pharmaceuticals Announces Presentations at SLEEP 2024NASDAQ:VNDAVanda Pharmaceuticals Inc
05/24/20243:49PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VNDAVanda Pharmaceuticals Inc
05/24/20243:46PMPR Newswire (US)Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its ShareholdersNASDAQ:VNDAVanda Pharmaceuticals Inc
05/24/20243:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VNDAVanda Pharmaceuticals Inc
05/24/20243:31PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VNDAVanda Pharmaceuticals Inc
05/21/20243:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VNDAVanda Pharmaceuticals Inc
05/21/20243:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VNDAVanda Pharmaceuticals Inc
05/21/20243:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VNDAVanda Pharmaceuticals Inc
05/21/20243:34PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VNDAVanda Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:VNDA

Your Recent History

NASDAQI
OMXI10GI
OMX Iceland 10 GI
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved